Category Archives: Mesenchymal Stem Cells

Fifty50 24K Gold Buy from Amazon US redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fexec%2Fobidos%2FASIN%2FB007927WAS%2Fhealth%5Fhope%2D20 Product Description Fifty50 24K Gold Experience the Anti-Aging Power of the New Generation 24K Nano Gold Stem Cell Therapy Mask. This excellent product by BeautyMedica Lab offers an innovative Transdermal Delivery System with a unique blend of transforming growth factors (TGF), amino acids, antioxidants and peptides.Sheet form of the mask makes it extremely easy to apply to the face and allowing the ingredients to be absorbed into the skin slowly melting under body temperature. The Mask was formulated to Re-activate stem cells and stimulate new skin development. Increase collagen production and elastin synthesis. Minimize appearance of fine lines and wrinkles. Enhance moisture with Y-PGA and refine skin structure. Whiten the skin and reduce melanin. Restore youthful healthy looking skin and creates radiant skin appearance.For more info, please visit 24K Gold Mask presentation video by Beauty Medical Laboratorys - http://www.youtube.com Disclaimer: Hope is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon. Amazon and the Amazon logo are trademarks of Amazon, Inc. or its affiliates.From:Mi WadsworthViews:0 0ratingsTime:00:58More inPeople Blogs View original … Continue reading →

New technique to deliver stem cell therapy may help damaged eyes regain their sight Engineers at the University of Sheffield have developed a new technique for delivering stem cell therapy to the eye which they hope will help the natural repair of eyes damaged by accident or disease.From:ResearchatSheffieldViews:0 0ratingsTime:01:31More inScience Technology Read the original post: New technique to deliver stem cell therapy may help damaged eyes regain their sight - Video … Continue reading →

MANILA, Philippines - A ranking official of the Catholic Bishops Conference of the Philippines (CBCP) considers immoral the embryonic stem cell therapy reportedly being used by politicians and actors for aesthetic purposes. In an interview with Radio Veritas, CBCP-Episcopal Commission on Bioethics Chairman and Malolos Bishop Jose Oliveros said this medical procedure is against the belief of the Church. He said they are still assessing if the same could be said for stem cells from animals. Pero yung sinasabi nila na pampabata sa mga politician at celebrities na sumailalim sa stem cell therapy ay immoral. Puwede namang ma-improve ang mukha ng isang tao, but it should be moral. Kapag gumamit ka ng immoral ay mali na yun, he said. Embryo is still a maturing fetus. He said the CBCP will come out with a pastoral statement regarding the matter once they are able to clarify certain matters with the Department of Health (DOH). The DOH earlier warned people from using stem cells from aborted babies and human embryos. The Philippine government will not allow the use of aborted fetuses or human embryosThere is a need to ensure that the biological raw materials are documented and validated and follow infection-free procedures, … Continue reading →

COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 9:00 a.m. ET in New York City. A live webcast of the presentation may be accessed through the Investors page of the Companys website at http://www.Osiris.com. A replay of the webcast will be available for one week following the conference. About Osiris Therapeutics Osiris Therapeutics, Inc., having developed the worlds first approved stem cell drug, Prochymal, is the leading stem cell company. The company is focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets. In Biosurgery, Osiris currently markets Grafix for burns and chronic wounds, and Ovation for orthopedic applications. Osiris is a fully integrated company with capabilities in research, development, manufacturing and distribution of stem cell products. Osiris has developed an extensive intellectual property portfolio to protect the company's technology, including 51 U.S. and 154 foreign patents. Osiris, Prochymal, Chondrogen, … Continue reading →

Provia Labs Store-A-Tooth dental stem cell banking will be featured as a new product at this weeks Greater New York Dental Meeting (GNYDM), exhibiting at booth #3333 to showcase their service and announce their initiative to support diabetes research, Stem Cells for a Cure. Lexington, MA (PRWEB) November 21, 2012 Dental professionals play an important role in spreading awareness about this option, to give patients the choice to bank their own stem cells from teeth that would otherwise be discarded during routine dental care. By incorporating the Store-A-Tooth service into their practices, the dental community has the unique opportunity to play a key role in their patients overall health, not just their oral health. Attendees at the Greater New York Dental Meeting can find out more by visiting Store-A-Tooth at Booth #3333. The company partners with dental offices to educate patients about the option to bank their familys stem cells. For those interested in the service, Store-A-Tooth makes it easy for patients and their dentists to collect teeth removed during normal dental procedures, such as when baby teeth come loose, wisdom teeth are extracted, or teeth are pulled for orthodontia. Samples are sent overnight to a state-of-the-art laboratory where theyre … Continue reading →

Clinical implantation of chondrotissue with concomitant surgical procedures This treatment video (by courtesy of Dr. Harold Vanderschmidt) includes partial resection of the lateral meniscus, ACL reconstruction with BTB graft, and the implantation of chondrotissue. For this purpose the cartilage defect was debrided up to the subchondral bone and then microfractured to allow the migration of mesenchymal stem cells into the scaffold. After measuring the defect size with a sterile template, the rehydrated chondrotissue was cut to fit the defect size, was implanted through a transpatellar portal and was fixed with fibrin glue.From:BioTissueAGViews:4 0ratingsTime:00:55More inPeople Blogs Read more: Clinical implantation of chondrotissue® with concomitant surgical procedures - Video … Continue reading →

What Are Stem Cells and Stem Cell Therapy Stemenhance http://www.stemcellproduct.net This video gives you the definition, facts, and understanding on what are stem cells, that there are two of them embryonic and adult stem cells, how they work and the uses of stem cell when the tissue is affected in your body and how messengers signal the bone marrow to release adult stem cells to help in the repair of the injured tissue. Why this information is exciting for me to do a video is because I see stemcells as the best way of how to produce optimal health in your body. The way I look at it is that optimal health equals the number of healthy cells in your body and the only way the body repairs a damaged area is by creating and sending adult stem cells to that area. That's why I'm introducing a stem cell product from a nutrition company who patented a stem cell enhancer which supports the release of adult stem cells. What will also excite you too is that Stemtech (the stemcell company) has also come out with two other products that will also optimize the circulation of these stem cells … Continue reading →

cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy http://www.cordbloodrecommendation.com These diseases include blood related, genetic and neurotic disorders. ""Banking the umbilical cord blood when your baby is born is a relatively new idea, the first operation using it to help cure a child with Leukemia was only done a little over 10 years ago. After processing of cells, comes the next procedure of cord blood preservation. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. With people not fully understanding how important stem cells could be for us, everybody agrees that more research need to be done in order to help understand all that. If there is any complication during … Continue reading →

The Irish Times - Monday, November 19, 2012 CLAIRE O'CONNELL Could a particular type of adult stem cell offer a useful therapy for diabetes? An EU-funded project being led by NUI Galway hopes to find out. The 6 million Reddstar project will assess whether the stem cells can tackle glucose levels and various complications of diabetes, including diabetic ulcers and eye, nerve, heart and kidney and bone damage. The approach centres on a specific adult stem-cell population owned by Orbsen Therapeutics, a spin-out from the Science Foundation Ireland-funded Regenerative Medicine Institute (Remedi) at NUI Galway. Initially, the project will develop ways to grow the bone-marrow-derived stem cells in a way that is useful for trials, according to company co-founder and Remedi director Prof Tim OBrien. The cells will then be tested in several preclinical models of diabetic complications at centres in Galway, Belfast, Munich, Berlin and Porto. Then the plan is to select one complication for which the adult stem cells will be assessed in human trials in Denmark. The three-year EU funding will support nine jobs in Ireland, five of which will be in Orbsen Therapeutics, according to CEO Brian Molloy, who says the project should help to build … Continue reading →

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Joseph C. Maroon, MD, FACS Neurosurgeon, Vice Chairman and Professor of the Department of Neurological Surgery at the University of Pittsburgh Medical Center (UPMC) has agreed to serve as Chairman of the Companys Medical and Scientific Advisory Board. Dr. Maroon is also the Heindl Scholar in Neuroscience at UPMC. San Diego, CA (PRWEB) November 19, 2012 Dr. Maroon is widely regarded as a premiere specialist in the surgical treatment of injuries and diseases of the brain and spine. His research into brain tumors, concussions and diseases of the spine have led to many innovative techniques for diagnosing and treating these disorders. He is the author of more than 250 peer-reviewed papers and 55 books or book chapters. Dr. Maroon commented, Stem cells are taking on an increasingly important role in the treatment of multiple neurological conditions. I have been impressed with Stemedicas credentials as a cGMP manufacturer of its proprietary lines of ischemic tolerant neural and mesenchymal stem cells that are licensed for use in clinical trials. These cells possess the important safety, potency, purity and immune-privileged characteristics that are needed in … Continue reading →